The presence of intralesional fat provides an invaluable tool for narrowing the differential diagnosis for both benign and malignant neoplasms of the abdomen and pelvis. The ability to characterize intralesional fat is further expanded by the ability of magnetic resonance imaging to detect small quantities (intravoxel) of fat. The differential diagnosis of fat-containing lesions arising in the liver is broader than that of many other solid organs. However, this differential can be further refined depending on the type of fat (macroscopic vs intravoxel) and with the use of ancillary imaging findings. Radiologists must be aware of benign and malignant mimickers of common lesions.
Introduction
Imaging plays an important role in noninvasive tissue characterization, which allows for the refinement of differential diagnoses and guides clinical management. Intralesional lipid or fat is a particularly useful finding at imaging because of the capacity for imaging to detect it and also because fatcontaining lesions often carry a narrow differential diagnosis. Intralesional fat can be divided into macroscopic or ''bulk'' fat, whereby lipid content occupies the majority of an image voxel, or intravoxel fat, whereby lipid and other soft tissue content coexist within an image voxel. 1 Intravoxel fat can be further subdivided into lesions in which mature adipocytes coexist with non-lipid-containing cells within the same image voxel (eg, fat poor renal angiomyolipoma [AML]) versus intracellular fat, whereby lesional cells themselves contain lipid content (eg, adrenal adenoma). 2 Macroscopic fat is typically well depicted at computed tomography (CT), both qualitatively (by comparison to subcutaneous or intra-/extraperitoneal fat) and quantitatively, with attenuation usually measuring less than À20 Hounsfield Units (HU). 1 At magnetic resonance imaging (MRI), macroscopic fat is characterized by hyperintense signal on T1-weighted (T1w) and T2-weighted (T2w) sequences with signal loss on fat-suppressed MR sequences, chemical shift artifact of the first kind in the frequency-encoding direction, and chemical shift artifact of the second kind (''India ink'' or ''etching'' artifact) around the lesion border on opposed-phase T1w gradient echo (GRE) images. India ink artifact is due to the interface where the lipid-containing lesion and non-lipid-containing surrounding soft tissue share the same voxel at the lesion border-the same principle which results in intralesional signal drop in lesions containing intravoxel fat.
As such, intravoxel fat is predominantly an MRI finding, characterized by signal loss on opposed-phase T1w GRE images in comparison to in-phase images. In particular circumstances, the presence of intravoxel fat may be inferred at CT. This is the case with adrenal adenomas, which may be diagnosed by an attenuation of less than 10 HU at nonenhanced CT (NECT), as the presence of intravoxel fat results in an attenuation lower than that of typical soft tissue. However, in most body sites, this is not a reliable conclusion given the overlap in attenuation of intravoxel fat with that of water. Indeed, part of the reason that such an inference is reliable in the adrenal gland is that adrenal cysts are exceedingly uncommon and both cysts and adenomas are benign.
The differential diagnosis of fat-containing lesions in the liver is broader than that of most other solid organs and is the focus of this review. Diagnostic considerations include both benign and malignant etiologies and depend greatly on whether macroscopic or intravoxel fat is present ( Figure 1 ).
Hepatic Adenoma
Adenomas are benign hepatocellular neoplasms, typically arising in noncirrhotic livers. They can be further divided into inflammatory, hepatocyte nuclear factor (HNF)-1a-mutated, and b-catenin-mutated subtypes. Inflammatory and HNF-1a-mutated subtypes are most common, accounting for approximately 85% of all hepatic adenomas, often in young women on oral contraceptives. 3 Intravoxel fat is characteristic of the HNF-1a-mutated (or ''steatotic'') subtype ( Figure 2 ) due to marked steatosis of the lesional hepatocytes (intracellular fat). 4 Precontrast, HNF-1a-mutated adenomas demonstrate iso-to mildly hyperintense signal on T1w and T2w sequences. 5 Post-gadolinium administration, these lesions demonstrate moderate arterial hyperenhancement, which does not persist on the more delayed phases and may mimic ''washout'' seen in hepatocellular carcinoma (HCC). 6 As such, the clinical setting is important in distinguishing HCC from adenomas.
Hepatocellular Carcinoma
Hepatocellular carcinoma is the most common primary liver malignancy, accounting for approximately 85% of cases, and typically occurring in patients with underlying cirrhosis or chronic liver disease (eg, viral hepatitis). 7 At contrastenhanced CT or MRI, the cardinal features of HCC include arterial phase hyperenhancement, washout to density/signal intensity below background liver parenchyma on portal venous and/or delayed phases, the presence of a pseudocapsule, and threshold growth (defined as !50% growth in <6 months). 8 Fatty metamorphosis of HCC is not uncommon, and intralesional fat can be identified in up to 35% of small (<1.5 cm) HCCs at histopathology, generally in well-to moderately differentiated tumours. 9 Typically, this will manifest as intravoxel fat, with signal drop on opposed-phase T1w GRE images and may be suggested at NECT (Figure 3) , with attenuation below À10 HU. 10 In some cases, the degree of fatty change may be sufficient to manifest as macroscopic fat. Intralesional fat within HCC may result in a hyperechoic appearance on ultrasound, mimicking a cavernous hemangioma, and imaging features may significantly overlap with those of steatotic adenomas. 3, 11 Therefore, any new focal liver lesion in a background cirrhotic liver should be viewed with suspicion.
Focal Hepatic Steatosis
True fat-containing liver neoplasms must be distinguished from hepatic steatosis, which is caused by the accumulation of triglyceride droplets within non-neoplastic hepatocytes. 12 Hepatic steatosis may be associated with alcoholic or nonalcoholic (eg, diabetes, obesity) etiologies and may be diffuse or focal in distribution. 12, 13 Focal hepatic steatosis often follows predictable patterns, such as deposition adjacent to the falciform ligament or gallbladder fossa (Figure 4) . Occasionally, focal steatosis may present in a multifocal pattern and/or with atypical distribution, in which case distinguishing it from a neoplastic etiology can be challenging. These lesions will typically show signal drop on opposed-phase T1w GRE images characteristic of intravoxel fat but with a geographic, ill-defined morphology and enhancement characteristics paralleling that of background liver. 13 Stability over time is also reassuring.
Hepatic AMLs
Hepatic AMLs are benign neoplasms composed of vascular (angio-), smooth muscle (myo-), and mature adipocyte (lipo-) elements and may be considered on the differential for liver lesions containing macroscopic fat. 14 Unlike their renal counterparts, hepatic AMLs are extremely uncommon, and only 6% are associated with underlying tuberous sclerosis, in which case they are likely to be multiple ( Figure 5 ). 15 Fat-poor hepatic AMLs may be indistinguishable from other liver neoplasms at imaging. 14 
Fat-Containing Liver Metastases
Fat-containing liver metastases are uncommon but may occur as a result of extrahepatic primary malignancies which may themselves demonstrate intralesional fat. For instance, intravoxel fat is a rare manifestation of metastatic spread of clear cell renal cell carcinoma (RCC) to liver. 16 Macroscopic fat can be seen in liposarcoma metastases, which may involve the liver in up to 10% of cases. 14 
Hydatid Cyst
Hydatid disease of the liver does not represent a neoplasm but rather represents sequelae of echinococcal infection and is characterized by a cystic lesion. Internal septations, floating membranes (''water lily'' sign), adjacent daughter cysts, and/or mural calcification may be features at crosssectional imaging. 17 Foci of macroscopic fat may be noted within the cyst, resulting in a fat-fluid level ( Figure 6 ), which is considered an indirect sign of erosion into the biliary tree. 18 
Pseudolipoma of Glisson's Capsule
Pseudolipoma of Glisson's capsule does not represent a true intrahepatic neoplasm, but rather is a well-encapsulated mass composed of homogeneous macroscopic fat density/signal, typically embedded in Glisson's capsule at the level of the hepatic dome (Figure 7) . The etiology is suspected to be related to migration of a colonic epiploic appendage to the level of the hepatic dome due to the normal flow of peritoneal fluid and subsequent entrapment at this level. 3 
Pseudolipoma of the Inferior Vena Cava
Pseudolipoma of the inferior vena cava (IVC) is a pseudolesion characterized by a macroscopic fat density/signal filling defect within the intrahepatic IVC on axial images (Figure 8 ). It is related to volume averaging artifact from pericaval fat adjacent to the caudate lobe. 19 
Summary
The presence of intralesional fat provides an invaluable tool for narrowing the differential diagnosis for both benign and malignant neoplasms of the liver. Intravoxel fat is characteristic of HNF-1a-mutated adenomas and well-to moderately differentiated HCC. Adenomas typically occur in young women on oral contraceptives, whereas HCC usually occurs on a background of chronic liver disease. Fat-containing metastases may also be considered if the lesions are multiple and there is a history of fat-containing primary malignancy, such as RCC. True lesions must be distinguished from focal fat deposition, which can at times be atypical in appearance and location. Macroscopic fat is uncommon in the liver but can be seen in hepatic AMLs or liposarcoma metastases. Occasionally, HCC or hydatid cysts may contain a component of macroscopic fat. These entities should be distinguished from pseudolipomas of Glisson's capsule or of the IVC, which are pseudolesions extrinsic to the liver or related to volume averaging, respectively, and have the appearance of circumscribed macroscopic fat.
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